Speakers

David P. Chelmow, MD is the Leo J. Dunn Professor of Obstetrics and Gynecology at Virginia Commonwealth University and has served as chair of OB/GYN since 2010. He completed his MD at Yale University Medical School and Residency at UCSF. Dr. Chelmow was the 2021-2022 ASCCP President. He serves on the US Preventive Services Task Force. He is past chair of the Women’s Preventive Services Initiative Multidisciplinary Steering Committee.

Teresa Darragh, MD is a Professor of Clinical Pathology in the Departments of Pathology and Obstetrics, Gynecology & Reproductive Sciences at the University of California, San Francisco. She is board certified in Anatomic Pathology and Cytopathology and was an attending colposcopist in UCSF’s Dysplasia Clinic for 25 years. Dr. Darragh’s primary clinical and research interests are focused on HPV-associated anogenital tract disease. She is Past President of the ASCCP and co-chaired the LAST Project on standardizing terminology for HPV-associated squamous lesions of the lower anogenital tract.

Levi S. Downs, Jr, MD, MS, is a gynecologic oncologist with Health Partners Park Nicollet. Dr. Downs received his medical degree from the University Of Pittsburgh School Of Medicine in Pittsburgh, Pennsylvania. He did his residency in obstetrics and gynecology at Magee-Women’s Hospital at the University of Pittsburgh Medical Center. Dr. Downs completed a fellowship in gynecologic oncology at the University of Minnesota and has a Master of Science degree in clinical research from the University Of Minnesota School of Public Health. Dr. Downs began his career at the University of Minnesota Medical School where he served as Chief of Gynecologic Oncology, Women’s Cancer Program Director at the Masonic Cancer Center and retired from the University of Minnesota after serving as Chief Medical Officer of University of Minnesota Physicians and University of Minnesota Health. He is currently Medical Director for Gynecologic Oncology at Health Partners Health System and is proudly serving on the organization’s Health Equity, Inclusion and Anti-Racism Cabinet. Dr. Downs has served as principal investigator for numerous clinical trials investigating ovarian and cervical cancers, chemotherapy, and therapeutic and preventive approaches to HPV related diseases. Among his many awards, Dr. Downs was recipient of the Robert Wood Johnson Foundation's Harold Amos Faculty Development Award. Among other societies Dr. Downs is also a member of the Society of Gynecologic Oncologists and is the 2023-2024 ASCCP President.

Linda Eckert, MD, is a Professor of Obstetrics and Gynecology, and Global Health at the University of Washington. She has been a long time consultant on cervical cancer screening for the World Health Organization, and has also worked with Ministries of Health for cervical cancer prevention in Namibia, Malawi, and Botswana and practiced medicine in Kenya and Nicaragua. She is the author of Enough: Because We Can Stop Cervical Cancer, published in January of 2024 by Cambridge University Press.

Mark H. Einstein, MD, MS is Professor and Chair of Obstetrics, Gynecology and Women's Health at Rutgers New Jersey Medical School. Dr. Einstein is a Gynecologic Oncologist who is an expert at identification and treatment of gynecologic malignancies. His primary research interests focus on the pathogenesis, therapy, and prevention of lower anogenital tract and gynecologic cancers. He leads numerous clinical efforts identifying unique targets and biomarkers for clinical risk of malignant transformation. He is also testing many novel drugs for cancer treatment. He has been an active leader for management guidelines and translating clinical trial and translational data for such organizations as the World Health Organization (WHO), American Cancer Society (ACS), Society of Gynecologic Oncology (SGO), American College of Obstetrics and Gynecology (ACOG), and Society of Lower Genital Tract Disease (ASCCP). He serves on the Boards for SGO and the ASCCP. He has served on numerous committees and leadership for the National Cancer Institute (NCI)-funded NRG Oncology group and AIDS Malignancy Consortium (AMC). Currently, he serves as a principal investigator on many multi-institutional clinical trials for gynecologic cancers in the US and Internationally. He has been funded for his research efforts by a number of organizations including the NCI, ACS, Foundation for Women's Cancers, and others.

Sarah Feldman, MD, MPH, is the Director Ambulatory Gynecologic Oncology and Center for Pre-invasive Disease of the Lower Genital Tract and Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School, Brigham and Women’s Hospital.

Lisa Flowers, MD, MPH, is Professor in the Department of Gynecology & Obstetrics at Emory University School of Medicine. Dr. Flowers joined the Emory faculty in 1999. She is active on many national and state committees aimed at improving the quality and delivery of care and service to patients with cervical and breast disease, including work with the American Society for Colposcopy and Cervical Pathology, American College of Obstetrics and Gynecology, and American Cancer Society. Dr. Flowers is a member of Alpha Omega Alpha Honor Society, the American College of Obstetricians and Gynecologists, International Anal Neoplasia Society and is a member and on the Board of Directors of American Society for Colposcopy and Cervical Pathology. She is also on the DHHS/CDC Breast and Cervical Cancer Early Detection and Control Advisory Committee. Dr. Lisa Flowers received her medical degree from Case Western Reserve University School of Medicine, in Cleveland, Ohio. She completed her residency in obstetrics and gynecology at Magee-Women’s Hospital of the University of Pittsburgh Medical Center in 1996. Dr. Flowers is board certified in obstetrics and gynecology. Dr. Flowers’ research interests include treatment for HPV-related disease, HPV and cervical cancer educational programs, and ovarian cancer surveillance for women with breast cancer susceptibility genes. She is currently the Emory Principal Investigator for several clinical trials entailing biomarker discovery, risk assessment and treatment for anal neoplasia.  Dr. Flowers was the 2022-2023 ASCCP President.

Francisco Garcia, MD, MPH is the Deputy County Administrator & Chief Medical Officer for Pima County in Arizona. He is currently the ASCCP 2023-24 President-Elect.

Patti E. Gravitt, PhD, MS is a molecular epidemiologist and implementation scientist whose research in HPV and cervical cancer spans the translational spectrum from natural history of cervical HPV across the lifespan to translation of evidence-based prevention tools to low- and middle-income countries. Dr. Gravitt has conducted several studies to clarify the role of HPV latency, diagnostic misclassification, cohort effects, and hysterectomy correction of cervical cancer incidence and mortality rates on the accuracy of our concept of cervical cancer risk in post-menopausal women. After nearly 20 years in academia, Dr. Gravitt joined the NCI in 2021 as Deputy Director for the Center for Global Health, where she leads implementation science efforts and provides scientific and programmatic direction across CGH's research, training, partnership, and dissemination goals.

Hope K. Haefner, MD is the Harold A. Furlong Professor of Women’s Health in the Department of Obstetrics and Gynecology at the University of Michigan Hospitals in Ann Arbor, Michigan where she received her medical degree. Dr. Haefner completed her obstetrics and gynecology residency at the University of Michigan Medical Center in 1990. She completed a fellowship in gynecologic pathology in 1993. Dr. Haefner is board certified in obstetrics and gynecology. She opened the University of Michigan Center for Vulvar Diseases in 1993. It is one of a few clinics in the United States that specializes in treating these conditions. She has a national and international reputation in this field. She is a specialist in vulvoscopy. She has a particular interest in high grade squamous intraepithelial lesions of the vulva, lichen sclerosus, lichen planus and hidradenitis suppurativa (including skin grafts and flaps for patients with Stage 3 hidradenitis suppurativa). She is the primary author of the Vulvodynia Guideline, published in 2005. Dr. Haefner is active in vulvovaginal disease research. She was a co-investigator on a R01 with Dr. Barbara Reed, the Longitudinal Population-Based Study of Vulvodynia. Dr. Haefner is Past President of ASCCP.

Warner K. Huh, MD is Professor, Vice Chair of Gynecology, Director of the Division of Gynecologic Oncology, and the Margaret Cameron Spain Endowed Chair in the Department of Obstetrics and Gynecology at the University of Alabama at Birmingham (UAB), Professor in the Department of Surgery, and Professor in the Department of Epidemiology in the UAB School of Public Health, and Senior Medical Officer and Senior Scientist in the UAB Comprehensive Cancer Center. His research interests include screening and prevention of HPV related diseases as well as novel immunotherapeutic approaches for pre-invasive disease of the cervix as well as cervical cancer. He has authored or co-authored over 225 articles in journals including The New England Journal of Medicine, Lancet, Lancet Oncology, Journal of the National Cancer Institute Cancer, Clinical Cancer Research, Gynecologic Oncology, Obstetrics & Gynecology, and the American Journal of Obstetrics & Gynecology (h-index: 47). He serves as co-PI of the Johns Hopkins-UAB-University of Colorado Cervical Cancer Specialized Programs of Research Excellence (SPORE) program (2P50CA098252-06A1). Dr. Huh serves on the editorial boards of Gynecologic Oncology and The Journal of Lower Genital Tract Disease. He is a Past President of ASCCP. Dr. Huh has also served on the Board of Directors for the Society of Gynecologic Oncology (SGO).

Michelle J. Khan, MD, MPH, is a board-certified obstetrician gynecologist with fellowship training in Reproductive Infectious Diseases. She is a Clinical Associate Professor at Stanford University School of Medicine. She works as a generalist seeing patients for routine Ob/Gyn care, pregnancy and delivery, and in subspecialty clinics focused on HPV-related diseases of the anogenital tract. She founded the PEACH Program at Stanford, which is a clinical program devoted to Prevention and Education of Anogenital Cancers and human papillomavirus (HPV)-associated diseases. She sees patients of any gender and is a faculty member in the Stanford LGBTQ+ Health Program. She is active in professional societies teaching national and international courses in colposcopy and high-resolution anoscopy and formulating guidelines for screening and management of HPV-related diseases. She serves as the Treasurer on the Executive Board for the American Society for Colposcopy and Cervical Pathology, as a member of the National Medical Committee of the Planned Parenthood Federation of America, and as the Co-Chair of the Education Task Force for the International Anal Neoplasia Society. She is also active in Diversity Equity and Inclusion including serving as Co-Director on the Stanford Department of Obstetrics and Gynecology DEI Committee and as a DEI committee member for the Infectious Diseases Society of Obstetricians and Gynecologists.

Jenna Marcus, MD Dr. Jenna Marcus is an Assistant Professor of Gynecologic Oncology at Northwestern Medicine. She is board certified in Obstetrics & Gynecology and Gynecologic Oncology and received her medical degree from Wayne State University prior to completing her residency training in Obstetrics and Gynecology at NYU Medical Center in New York and fellowship in Gynecologic Oncology at Albert Einstein College of Medicine/Montefiore Medical Center in the Bronx. She was an Assistant Professor and the Chief of Clinical Research for Gynecologic Oncology at Rutgers University prior to joining the faculty at Northwestern. Dr. Marcus is a leader in the field and serves on several national committees including, the Society of Gynecologic Oncology, American Cancer Society and American Society for Colposcopy and Cervical Pathology. She is also the co-chair of several national committees focused on cervical cancer screening, detection and management of premalignant conditions. Dedicated to research, she has been the principal investigator on multiple trials in both the treatment and prevention of gynecologic malignancies. Dr. Marcus is on the editorial board of the Journal of Lower Genital Tract Disease and has co-authored many peer-reviewed articles.

Dr. L. Stewart Massad led the writing group for the update to the 2017 ASCCP Colposcopy Standards on ECC at colposcopy. He was co-lead for the writing group that developed guidelines for the management of HPV+ women being triaged with dual stain testing. Dr. Massad is a professor in the Division of Gynecologic Oncology at Washington University in St. Louis.

Dr. Mauricio Maza is the Regional Advisor for cancer prevention and control at PAHO/WHO. He was the Executive Director of Basic Health International (BHI), where he worked for over 17 years before joining PAHO. He received his degree as Doctor of Medicine from the Universidad Dr. Jose Matías Delgado in El Salvador, and his Master of Public Health from Harvard University with a concentration in Health Care Management and Policy. In 2015 Dr. Maza was named as a Young Leader by the Union for International Cancer Control (UICC) and in 2016 he was chosen to be part of the International Agency for Research in Cancer of the World Health Organization (IARC) “50 for 50” initiative which goal was to identify 50 future leaders in cancer research from low- and middle-income countries. Dr. Maza believes in the need to advocate for more research and evidence-based health policies in limited resource settings.

Anna-Barbara Moscicki, MD, is Professor of Pediatrics at UCLA, Division Chief of Adolescent and Young Adult Medicine, and Associate Vice Chair of Clinical Research, Department of Pediatric. Dr. Moscicki is Past President for the ASCCP. Dr. Moscicki’s career has focused on adolescent gynecology and sexually transmitted infection research with a specific focus in Human Papillomavirus, HIV infection and mucosal immunology. Dr. Moscicki has been the principal investigator of a natural history study of HPV in adolescents and young women since 1990, one of the longest running HPV cohorts. Her work was highly influential in forming the new cervical cancer screening guidelines and triage of abnormal cytology in young women. Her recent work focuses on mucosal immunology and the vaginal microbiota. She has been involved in numerous clinical trials including vaginal microbiocides and an ongoing one dose HPV vaccine trial. She is also involved in health outcomes in perinatally HIV infected children including HPV vaccine efficacy, sexual risk behaviors, substance use, oral health, microbiomes, and HPV infections and has worked with numerous Networks on HIV disease in children and adolescents including Adolescent Medicine HIV/AIDS Research Network, Adolescent Therapeutic Network, IMPAACT and PHACS. She has over 150 publications and she serves on numerous national and international committees, including the W.H.O., N.I.H., ASCCP, and the American Cancer Society.

Chemtai Mungo, MD, MPH, is passionate about using research, advocacy, and capacity-building to pursue global women’s health equity. Her primary research is focused on increasing access to effective, evidence-based cervical cancer prevention in low-income countries, including investigating resource-appropriate and effective methods of treating cervical precancer, especially among women living with HIV in low-resource settings. She is also studying dysplasia treatment outcomes following thermal ablation in low-resource settings.

Erin L. Nelson, MD, is Professor and Vice-Chair of Education in the Department of Obstetrics and Gynecology at the University of Texas School of Medicine at San Antonio. She is a distinguished teaching professor and Board of Directors Member for the SOM Academy of Teaching Scholars. Dr. Nelson is the director of colposcopy services and Brady Green Dysplasia clinic since 2011. She has served on multiple American Society of Colposcopy and Cervical Pathology (ASCCP) national committees and is currently on their Board of Directors. Her special interests are medical education, curriculum development, HPV, and cervical dysplasia.

Rebecca Perkins, MD, MSc is a Professor of Obstetrics and Gynecology at Boston University Chobanian and Avedisian School of Medicine, and a practicing gynecologist at Boston Medical Center. Her career is dedicated to reducing health disparities in cervical cancer. Her current research focuses on improving utilization of HPV vaccination and cervical cancer screening guidelines. Dr. Perkins has worked on national projects related to HPV vaccination and cervical cancer prevention with the National Cancer Institute, American Cancer Society, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists. For ASCCP, she has been a working group member for the Colposcopy Standards project, Co-Chair and Chair of the Practice Committee, Co-Chair of the 2019 ASCCP Risk-Based Management Consensus Guidelines, and currently serves as a member of the App Task Force.

Lisa Rahangdale, MD, MPH, is a Professor of Obstetrics and Gynecology and Associate Dean for Admissions at the University of North Carolina School of Medicine. Her research interests lie in understanding how infectious diseases affect the reproductive health of women and how to optimize primary and secondary prevention measures.

Vikrant Sahasrabuddhe, MPH, MBBS, DrPH is Deputy Chief of the Breast and Gynecologic Cancer Research Group and Program Director in the Division of Cancer Prevention at the National Cancer Institute overseeing prevention clinical research on cervical cancer and other human papillomavirus (HPV)-related cancers. Dr. Sahasrabuddhe provides scientific direction and strategic guidance for efforts on optimization of clinic-based and population-based precision prevention strategies for cervical cancer and other HPV-related cancers and building the evidence base for their implementation in the United States and globally.

Mila Pontremoli Salcedo, MD, PhD, is an Instructor and Director of Training & Education programs for cervical cancer prevention in Mozambique, Texas and other low-resource settings at The Department of Gynecologic Oncology & Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston/Texas. Dr. Salcedo is the co-Chair of Preinvasive Program at the International Gynecologic Cancer Society and the International Affairs Advisor for Teaching and Research at Santa Casa Hospital in Porto Alegre, Brazil. Dr. Salcedo served as an Associate Professor in the Department of Obstetrics and Gynecology at the Federal University of Health Sciences of Porto Alegre (UFCSPA)/Brazil, where she was the Director of the Gynecology and Obstetrics Department at UFCSPA and the Chair and Director of Gynecology at Santa Casa de Misericordia Hospital of Porto Alegre, Brazil. Her primary research interests are in HPV, cervical and vulvar cancer prevention, and lower genital tract disease, especially in low resource settings.

Debbie Saslow, PhD, is the Strategic Director for Screening and Vaccination at the American Cancer Society where she has worked since 1997. Dr. Saslow serves as the ACS lead for HPV-related cancers and directs their HPV vaccination nationwide priority program of work, provides strategic direction and leads staff teams working on the implementation of HPV related activities, and provides evidenced-based guidance to the organization on cancer screening and vaccination. She is responsible for developing and updating ACS guidelines, including guidelines for cervical cancer screening and for HPV vaccination. Dr. Saslow also serves as the Tri-Chair of the ACS National HPV Vaccination Roundtable and the ACS National Roundtable on Cervical Cancer. Dr. Saslow received her undergraduate degree in biology with honors from Brown University, her PhD in human and molecular genetics from Yale University, and completed a post-doctoral fellowship at the National Cancer Institutes’ Laboratory of Pathology in Women’s Cancers.

Peter F. Schnatz, DO, MBA, FACOG, FACP, NCMP, is the Associate Chairman and Residency Program Director in the Dept of ObGyn at The Reading Hospital in PA. Dr. Schnatz is an Internist and ObGyn and is a Professor at Drexel University. Dr. Schnatz is a Past President of the North American Menopause Society (NAMS) and the Philadelphia ObGyn Society. He is on the Board of Advisors to The Advancing Health After Hysterectomy Foundation, Inc. and is on a number of Editorial Boards. Dr. Schnatz is a regular faculty member for ASCCP courses, is a past Chair of the ASCCP education committee, and is on the ASCCP Board of Directors. He is a past CREOG Region II Program Director’s Representative to the CREOG Council as well as a number of ACOG committees, is an ABOG oral board examiner, and a reviewer for multiple journals. He is an editorial Board member for SASGOG’s Pearls of Excellence, is the Vice Chair – Pearls Publications Committee, and is the Editor-in-Chief of SASGOG’s newest book. He currently serves as the Chair of the Education Committee for the International Menopause Society (IMS). Dr. Schnatz is the Founder, Chairman of the Board, and CEO of FaithCare, Incorporated, an organization involved in humanitarian aid both locally and internationally. Schnatz is a NAMS Certified Menopause Practitioner and is actively involved as both a clinician and a researcher. Dr. Schnatz has well over 200 publications, with at least 140 of those as peer reviewed medical articles and many award-winning papers and/or presentations. Dr Schnatz graduated from the Rowan University School of Osteopathic Medicine and completed his Internal Medicine and ObGyn residencies at UConn, in Farmington, CT.

Alan G. Waxman, MD, MPH, is Emeritus Professor of Obstetrics and Gynecology at the University of New Mexico (UNM) in Albuquerque, NM. He completed his medical degree and ob/gyn residency at the University of Colorado and his Masters of Public Health at Emory University. He joined the faculty of UNM in 2000 after completing a 24 year career with the Indian Health Service (IHS). Dr. Waxman’s principle area of interest since 1991 has been cervical cancer screening and prevention. He has been director of the IHS Colposcopy Courses annually since 1992. He served on numerous committees of ASCCP including 14 years on the Board of Directors and was the Society’s President 2012-2013. In 2018 he was awarded ASCCP’s Lifetime Achievement Award. He has lectured nationally and internationally on cervical cancer prevention, human papillomavirus and colposcopy. He has authored numerous articles and book chapters on colposcopy, cervical cancer screening, and related subjects. Dr. Waxman retired from clinical practice in 2020. He remains actively involved in numerous academic projects related to cervical cancer prevention, and continues to teach colposcopy throughout the U.S. and internationally.

Nicolas Wentzensen, MD, PhD, received an M.D. in 2000 and a Ph.D. in Applied Tumor Biology in 2007, both from the University of Heidelberg. He conducted research in molecular biology, molecular pathology, and molecular epidemiology at the Department of Surgery and at the Institute of Pathology, University of Heidelberg. He built a research group focusing on cervical cancer biomarker discovery and validation and established a diagnostic laboratory for cervical cancer screening. In 2009 he earned a Master of Science in Epidemiology from the University of Mainz. Dr. Wentzensen joined DCEG as a visiting fellow in 2007, became a tenure-track investigator in 2009, and was awarded scientific tenure by the NIH and appointed senior investigator in 2013. In 2015 he joined the Clinical Genetics Branch as Deputy Chief and head of the newly formed Clinical Epidemiology Unit (CEU) within CGB. Dr. Wentzensen’s research is focused on clinical epidemiology of gynecological cancers.

Gabrielle Whitmore, MD, MBS, is a board-certified OBGYN who completed her residency at the University of Colorado School of Medicine and fellowship in Minimally Invasive Gynecologic Surgery at the University of Michigan. She is currently a faculty member at the University of Colorado, where she serves as the Co-Director of the Center for Endometriosis and Chronic Pelvic Pain, Minimally Invasive Gynecologic Surgery Rotation Assistant Program Director, and is on the DEI Executive Board. She focuses her time on patient and resident education in the evaluation and management of chronic pelvic pain, as well as research in racial disparities and pelvic pain conditions.